Genomtec Valuation Multiples

Genomtec Overview

About Genomtec

Genomtec SA is an technology company which works in the area of ​​ molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Founded

2016

HQ

Employees

N/A

Website

genomtec.com

Sectors

Medical DevicesHealthTech

Financials (FY)

Revenue: $0K

EBITDA: ($2M)

EV

$18M

Valuation Multiples

Multiples.vc

Start free trial

Genomtec Financials

Genomtec reported last fiscal year revenue of $0K and negative EBITDA of ($2M).

In the same fiscal year, Genomtec generated $0K in gross profit, ($2M) in EBITDA losses, and had net loss of ($3M).

Genomtec P&L

In the most recent fiscal year, Genomtec reported revenue of $0K and EBITDA of ($2M).

Genomtec expects next 12-month revenue of XXX and NTM EBITDA of XXX

Genomtec Stock Performance

Genomtec has current market cap of $19M, and enterprise value of $18M.

Genomtec's stock price is $1.27.

Genomtec Valuation Multiples

Genomtec trades at 63498.1x EV/Revenue multiple, and (7.3x) EV/EBITDA.

Genomtec Financial Valuation Multiples

As of April 20, 2026, Genomtec has market cap of $19M and EV of $18M.

Equity research analysts estimate Genomtec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Genomtec has a P/E ratio of (6.1x).

Genomtec Margins & Growth Rates

Genomtec's revenue in the last fiscal year grew by 0%.

Genomtec Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Genomtec M&A Activity

Genomtec acquired XXX companies to date.

Last acquisition by Genomtec was on XXXXXXXX, XXXXX. Genomtec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Genomtec Investment Activity

Genomtec invested in XXX companies to date.

Genomtec made its latest investment on XXXXXXXX, XXXXX. Genomtec invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).